Valuation: Avantor, Inc.

Market Cap 6.66B 5.84B 5.4B 4.99B 9.45B 638B 9.64B 64.87B 25.2B 312B 25.02B 24.48B 1,084B P/E 2026 *
27.1x
P/E 2027 * 22.6x
Enterprise Value 9.68B 8.49B 7.84B 7.24B 13.72B 926B 14B 94.19B 36.6B 453B 36.34B 35.54B 1,574B EV / Sales 2026 *
1.49x
EV / Sales 2027 * 1.36x
Free-Float
95.54%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 2025-08-17
Director of Finance/CFO 50 2026-06-23
Chief Operating Officer - 2025-11-09
Director TitleAgeSince
Director/Board Member 60 2020-04-21
Chairman 69 2025-12-31
Director/Board Member 62 2021-09-30
Date Insider Type Main position Quantity % Market Cap.
06-20Tax

Executive/Senior Manager

-3,010 0.0004%
05-07Buy

Director

10,000 0.0015%
05-06Free

Director

25,270 0.0037%
Change 5-day change 1-year change 3-year change Capi.($)
+8.66%-2.50% - - 6.66B
-0.60%-1.01%-29.11%-11.75% 166B
+0.93%-0.65%-7.13%-4.40% 105B
-1.64%+2.50%+1.25%+57.61% 60.23B
+3.64%-4.34%+45.42%+51.88% 49.17B
+0.12%-4.57%-14.04%-41.43% 41.49B
+1.59%-5.58% - - 34.08B
-2.57%+1.52%-14.78%-44.63% 28.58B
+1.54%-1.48%+59.30%-4.50% 24.99B
-2.15%+3.29%-9.38%+3.10% 20.64B
Average +0.98%+1.15%+3.94%+0.74% 53.66B
Weighted average by Cap. +0.21%+2.06%-6.02%+1.15%

Financials

2026 *2027 *
Net sales 6.5B 5.7B 5.27B 4.87B 9.22B 623B 9.41B 63.29B 24.59B 305B 24.42B 23.88B 1,058B 6.64B 5.82B 5.38B 4.97B 9.42B 636B 9.6B 64.63B 25.11B 311B 24.93B 24.39B 1,080B
Net income 244M 214M 197M 182M 346M 23.35B 353M 2.37B 922M 11.43B 916M 896M 39.67B 289M 253M 234M 216M 410M 27.67B 418M 2.81B 1.09B 13.54B 1.09B 1.06B 47.01B
Net Debt 3.01B 2.64B 2.44B 2.25B 4.27B 288B 4.36B 29.32B 11.39B 141B 11.31B 11.06B 490B 2.36B 2.07B 1.91B 1.77B 3.35B 226B 3.42B 23B 8.94B 111B 8.87B 8.68B 384B
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Employees
13,500
Date Price Change Volume
26-07-09 US$10.44 +6.92% 3,612,518
26-07-08 US$9.760 -4.31% 6,986,828
26-07-07 US$10.20 -1.64% 6,932,139
26-07-06 US$10.37 +0.48% 7,512,090
26-07-02 US$10.32 +3.10% 8,327,589
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
9.760USD
Average target price
10.06USD
Spread / Average Target
+3.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AVTR Stock